Bicara Therapeutics Files Q1 2025 10-Q
Ticker: BCAX · Form: 10-Q · Filed: May 13, 2025 · CIK: 2023658
| Field | Detail |
|---|---|
| Company | Bicara Therapeutics Inc. (BCAX) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Bicara Therapeutics Q1 2025 10-Q is in. Check financials.
AI Summary
Bicara Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, located at 245 Main Street, Cambridge, MA, reported financial information for the first quarter of 2025. Key financial data and business operations are detailed in this filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational updates for Bicara Therapeutics for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information and operational updates which can significantly impact investment decisions, but it does not represent a new event or crisis.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Covers the first quarter of 2025)
- 2025-05-13 — Filing Date (Date the 10-Q was submitted to the SEC)
Key Players & Entities
- Bicara Therapeutics Inc. (company) — Filer of the 10-Q
- 245 MAIN STREET, CAMBRIDGE, MA 02142 (location) — Business and Mail Address
- 001-42271 (identifier) — SEC File Number
- 25940219 (identifier) — Film Number
FAQ
What is the SEC file number for Bicara Therapeutics Inc.?
The SEC file number for Bicara Therapeutics Inc. is 001-42271.
What is the business address of Bicara Therapeutics Inc.?
The business address of Bicara Therapeutics Inc. is 245 MAIN STREET, CAMBRIDGE, MA 02142.
For what period is this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filed?
This 10-Q was filed on May 13, 2025.
What is the Standard Industrial Classification for Bicara Therapeutics Inc.?
The Standard Industrial Classification for Bicara Therapeutics Inc. is PHARMACEUTICAL PREPARATIONS [2834].
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Bicara Therapeutics Inc. (BCAX).